open access

Vol 13, No 5 (2006): Folia Cardiologica
Original articles
Published online: 2006-05-25
Get Citation

Sex hormone plasma levels in premenopausal women with coronary heart disease

Agnieszka Okraska-Bylica, Andrzej Paradowski, Jerzy Matysek, Urszula Czubek, Wiesława Piwowarska
Folia Cardiol 2006;13(5):423-426.

open access

Vol 13, No 5 (2006): Folia Cardiologica
Original articles
Published online: 2006-05-25

Abstract

Background: Coronary heart disease (CHD) in premenopausal women is rare. This may be related to the protective effect of endogenous estrogens on the female cardiovascular system. The aim of the study was to analyse the levels of sex hormones in premenopausal women with CHD confirmed by coronary angiography.
Methods: Thirty women aged 34–53 years and with a mean age of 46.3 ± 5.2 years were enrolled in the study. All were regularly menstruating, in the premenopausal period (i.e. with FSH < 15 IU/L and FSH > LH), with stable CHD and with significant atherosclerotic plaques in coronary angiography (narrowings > 50% of the lumen diameter). Of these, 80% had myocardial infarction in their histories. Estradiol plasma levels and gonadotrophic hormone (luteinising hormone LH and follicle-stimulating hormone FSH) plasma levels were measured in the women under investigation.
Results: A diminished estradiol level was diagnosed in 14 patients (46.7%) of the 30 premenopausal women examined (patients with hypoestrogenemia). In 12 women (40%) hypoestrogenemia was accompanied by diminished levels of gonadotrophins (hypoestrogenaemia of hypothalamic origin).
Conclusion: The plasma estradiol level was diminished in 46.7% of premenopausal women with CHD. Insufficient level of endogenous estradiol could have contributed to the early development of atherosclerotic plaques in the epicardial coronary arteries of the women examined.

Abstract

Background: Coronary heart disease (CHD) in premenopausal women is rare. This may be related to the protective effect of endogenous estrogens on the female cardiovascular system. The aim of the study was to analyse the levels of sex hormones in premenopausal women with CHD confirmed by coronary angiography.
Methods: Thirty women aged 34–53 years and with a mean age of 46.3 ± 5.2 years were enrolled in the study. All were regularly menstruating, in the premenopausal period (i.e. with FSH < 15 IU/L and FSH > LH), with stable CHD and with significant atherosclerotic plaques in coronary angiography (narrowings > 50% of the lumen diameter). Of these, 80% had myocardial infarction in their histories. Estradiol plasma levels and gonadotrophic hormone (luteinising hormone LH and follicle-stimulating hormone FSH) plasma levels were measured in the women under investigation.
Results: A diminished estradiol level was diagnosed in 14 patients (46.7%) of the 30 premenopausal women examined (patients with hypoestrogenemia). In 12 women (40%) hypoestrogenemia was accompanied by diminished levels of gonadotrophins (hypoestrogenaemia of hypothalamic origin).
Conclusion: The plasma estradiol level was diminished in 46.7% of premenopausal women with CHD. Insufficient level of endogenous estradiol could have contributed to the early development of atherosclerotic plaques in the epicardial coronary arteries of the women examined.
Get Citation

Keywords

women; coronary heart disease; estradiol

About this article
Title

Sex hormone plasma levels in premenopausal women with coronary heart disease

Journal

Cardiology Journal

Issue

Vol 13, No 5 (2006): Folia Cardiologica

Pages

423-426

Published online

2006-05-25

Bibliographic record

Folia Cardiol 2006;13(5):423-426.

Keywords

women
coronary heart disease
estradiol

Authors

Agnieszka Okraska-Bylica
Andrzej Paradowski
Jerzy Matysek
Urszula Czubek
Wiesława Piwowarska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl